Friendswood, TX, United States of America

Sarah J Kurley

This inventor holds 2 USPTO granted patents and 7 published patent applications. Top assignee: Castle Biosciences, Incorporated. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sarah J Kurley. Retrieved from https://idiyas.com/inventor/sarah-j-kurley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Sarah J Kurley

Introduction

Sarah J Kurley is a prominent inventor based in Friendswood, TX (US). She has made significant contributions to the field of oncology, particularly in the diagnosis and treatment of cutaneous squamous cell carcinoma (cSCC). With a total of 2 patents, her work is paving the way for advancements in cancer care.

Latest Patents

Kurley's latest patents focus on innovative methods for diagnosing and treating patients with cutaneous squamous cell carcinoma. The present disclosures relate to methods for predicting the risk of recurrence and/or metastasis in primary cSCC. These advancements are crucial for improving patient outcomes and tailoring treatment plans.

Career Highlights

Sarah J Kurley is currently associated with Castle Biosciences, Incorporated, where she continues to develop her groundbreaking work in cancer diagnostics. Her expertise and dedication to research have positioned her as a leader in her field.

Collaborations

Some of her notable coworkers include Robert Willis Cook and Kyle R Covington, who contribute to the collaborative efforts in advancing cancer treatment methodologies.

Conclusion

Sarah J Kurley's innovative work in the field of oncology exemplifies the impact of dedicated research on patient care. Her contributions are vital in the ongoing fight against cancer, particularly in enhancing the understanding and treatment of cutaneous squamous cell carcinoma.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…